Changes in migraine treatment: how new classes of drugs can provide additional options for patients and prescribers This episode of The PJ Pod looks at recent changes to National Institute for Health and Care Excellence guidance on the treatment of acute and chronic migraine and what pharmacists should expect from the new class of gepant drugs.…
NICE recommends tenecteplase for treating acute ischaemic stroke patients Tenecteplase was found to be as effective as alteplase, which is more expensive, and the National Institute for Health and Care Excellence said its decision could save the NHS “millions”.…
ADHD hub planned for launch in autumn 2024 The hub will support shared-care arrangement for adults with attention deficit hyperactivity disorder in Leeds, West Yorkshire.…
ADHD drugs back in stock, says manufacturer Exclusive: Medicines used to treat ADHD manufactured by Takeda are now available, following a period of supply issues caused by an increase in demand and production challenges.…
More than 40% of people with ADHD waiting at least two years to access mental health service, study finds Healthcare professionals, integrated care board commissioners and people with lived experience of ADHD all reported extended wait times for adult mental health services.…
Erectile dysfunction drugs may reduce Alzheimer’s risk, study suggests Results from a study of more than 260,000 men has suggested those taking erectile dysfunction drugs were 18% less likely to develop Alzheimer's disease than those not taking the drugs.…
How our integrated care system is taking steps to minimise the risks of sodium valproate North Central London Integrated Care System has piloted new guidelines and a local dashboard to ensure there is a safety net in place for females taking sodium valproate.…
Pharmacists can do more to bridge the safety gaps for people with learning disabilities People with learning disabilities are more likely to be taking multiple medicines, but labels are not designed with them in mind — it is time to pay more attention to this patient group’s needs.…
Second ADHD medication shortage leaves patients in ‘very difficult position’, pharmacists warn A medicine supply notification warned that atomoxetine 40mg and 60mg capsules will be out of stock until September 2023…
Special report: charting the rise in ADHD prescribing Despite a rise in people receiving treatment for attention deficit hyperactivity disorder in England, particularly adults, data show the condition continues to be significantly underdiagnosed.…
